Yik A Yeung

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 10

Top Topics

Dendritic Cells

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Kelly D Moynihan, Manu P Kumar, Hussein Sultan, Danielle C Pappas, Terrence Park, S Michael Chin, Paul Bessette, Ruth Y Lan, Henry C Nguyen, Nathan D Mathewson, Irene Ni, Wei Chen, Yonghee Lee, Sindy Liao-Chan, Jessie Chen, Ton N M Schumacher, Robert D Schreiber, Yik A Yeung, Ivana M Djuretic
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity. Cancer discovery 14 (7) (2024)
Kelly D Moynihan, Manu P Kumar, Hussein Sultan, Danielle C Pappas, Terrence Park, S Michael Chin, Paul Bessette, Ruth Y Lan, Henry C Nguyen, Nathan D Mathewson, Irene Ni, Wei Chen, Yonghee Lee, Sindy Liao-Chan, Jessie Chen, Ton N M Schumacher, Robert D Schreiber, Yik A Yeung, Ivana M Djuretic
IL-2 targeted to CD8+ T cells promotes robust effector T cell responses and potent antitumor immunity. Cancer discovery (2024)
Paulien Kaptein, Nadine Slingerland, Christina Metoikidou, Felix Prinz, Simone Brokamp, Mercedes Machuca-Ostos, Guido de Roo, Ton N M Schumacher, Yik A Yeung, Kelly D Moynihan, Ivana M Djuretic, Daniela S Thommen
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool. Cancer discovery 14 (7) (2024)
Kelly D Moynihan, Manu P Kumar, Hussein Sultan, Danielle C Pappas, Terrence Park, S Michael Chin, Paul Bessette, Ruth Y Lan, Henry C Nguyen, Nathan D Mathewson, Irene Ni, Wei Chen, Yonghee Lee, Sindy Liao-Chan, Jessie Chen, Ton N M Schumacher, Robert D Schreiber, Yik A Yeung, Ivana M Djuretic
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity. Cancer discovery 14 (7) (2024)
Paulien Kaptein, Nadine Slingerland, Christina Metoikidou, Felix Prinz, Simone Brokamp, Mercedes Machuca-Ostos, Guido de Roo, Ton N M Schumacher, Yik A Yeung, Kelly D Moynihan, Ivana M Djuretic, Daniela S Thommen
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool. Cancer discovery 14 (7) (2024)
Paulien Kaptein, Nadine Slingerland, Christina Metoikidou, Felix Prinz, Simone Brokamp, Mercedes Machuca-Ostos, Guido de Roo, Ton N M Schumacher, Yik A Yeung, Kelly D Moynihan, Ivana M Djuretic, Daniela S Thommen
CD8-targeted IL2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T cell pool. Cancer discovery (2024)
Paulien Kaptein, Nadine Slingerland, Christina Metoikidou, Felix Prinz, Simone Brokamp, Mercedes Machuca-Ostos, Guido de Roo, Ton N M Schumacher, Yik A Yeung, Kelly D Moynihan, Ivana M Djuretic, Daniela S Thommen
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool. Cancer discovery 14 (7) (2024)
Kelly D Moynihan, Manu P Kumar, Hussein Sultan, Danielle C Pappas, Terrence Park, S Michael Chin, Paul Bessette, Ruth Y Lan, Henry C Nguyen, Nathan D Mathewson, Irene Ni, Wei Chen, Yonghee Lee, Sindy Liao-Chan, Jessie Chen, Ton N M Schumacher, Robert D Schreiber, Yik A Yeung, Ivana M Djuretic
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity. Cancer discovery 14 (7) (2024)
Paulien Kaptein, Nadine Slingerland, Christina Metoikidou, Felix Prinz, Simone Brokamp, Mercedes Machuca-Ostos, Guido de Roo, Ton N M Schumacher, Yik A Yeung, Kelly D Moynihan, Ivana M Djuretic, Daniela S Thommen
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool. Cancer discovery 14 (7) (2024)
Kelly D Moynihan, Manu P Kumar, Hussein Sultan, Danielle C Pappas, Terrence Park, S Michael Chin, Paul Bessette, Ruth Y Lan, Henry C Nguyen, Nathan D Mathewson, Irene Ni, Wei Chen, Yonghee Lee, Sindy Liao-Chan, Jessie Chen, Ton N M Schumacher, Robert D Schreiber, Yik A Yeung, Ivana M Djuretic
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity. Cancer discovery 14 (7) (2024)